Achieve Whole Recovery, PC
Achieve Whole Recovery, PC was paid $22.64M by Medicaid between Jan 2018 and Dec 2024, across 52 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 19% of everything it billed.
33Billing provider infoACHIEVE WHOLE RECOVERY, PC
COLORADO SPRINGS, CO 80907
COLORADO SPRINGS, CO 80907
33aNPI1013456383assigned 02/19/2017
33bProvider typeSpecialist
28Total paid$22.64M
24GClaims328,222
24DCodes billed52
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Colorado
Rank by total paid#1 of 124
Median peer was paid$37K
This provider vs. median617×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,339 | $827K | |
| 2019 | 39,712 | $2.33M | |
| 2020 | 43,332 | $3.22M | |
| 2021 | 97,746 | $6.21M | |
| 2022 | 39,949 | $3.06M | |
| 2023 | 46,670 | $3.53M | |
| 2024incomplete | 41,474 | $3.47M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 19% | 50,856 | 39,100 | $4.31M |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 19% | 21,202 | 14,852 | $4.20M |
| Q9992 | Injection, buprenorphine extended-release (sublocade), greater than 100 mg | 17% | 2,407 | 2,274 | $3.84M |
| J2315 | Injection, naltrexone, depot form, 1 mg | 5.5% | 993 | 949 | $1.24M |
| Q9991 | Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg | 5.3% | 731 | 701 | $1.20M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 5.0% | 12,903 | 5,964 | $1.14M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 4.9% | 8,520 | 6,838 | $1.10M |
| 82075 | 4.6% | 41,641 | 31,027 | $1.04M | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | 3.2% | 4,594 | 3,955 | $731K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.4% | 10,265 | 7,654 | $548K |
| 80305 | 2.4% | 45,181 | 32,671 | $540K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 2.0% | 12,830 | 10,285 | $446K |
40 more codes
| 99205 | Prolong outpt/office vis | 1.4% | 1,885 | $320K |
| 99204 | Doctor's office visit, new patient (more involved) | 1.1% | 1,963 | $258K |
| 81025 | <1% | 19,936 | $158K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 882 | $117K |
| 99355 | <1% | 739 | $101K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 1,623 | $97K |
| 99354 | <1% | 813 | $57K | |
| 80362 | <1% | 3,085 | $52K | |
| 80345 | <1% | 3,086 | $52K | |
| 80356 | <1% | 3,086 | $52K | |
| 80349 | <1% | 3,086 | $52K | |
| 80324 | <1% | 3,086 | $52K | |
| 80358 | <1% | 3,086 | $52K | |
| 80354 | <1% | 3,086 | $52K | |
| 80365 | <1% | 3,085 | $52K | |
| 80369 | <1% | 3,084 | $52K | |
| 80346 | <1% | 3,086 | $52K | |
| 80321 | <1% | 3,087 | $52K | |
| 80361 | <1% | 3,084 | $52K | |
| 80348 | <1% | 3,086 | $52K | |
| 80373 | <1% | 3,084 | $52K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,647 | $50K |
| 80355 | <1% | 2,558 | $43K | |
| 80357 | <1% | 2,558 | $43K | |
| 80368 | <1% | 2,556 | $43K | |
| 80366 | <1% | 2,556 | $43K | |
| 80359 | <1% | 2,557 | $43K | |
| 80360 | <1% | 2,557 | $43K | |
| 80372 | <1% | 2,556 | $43K | |
| 99000 | <1% | 17,463 | $35K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 246 | $24K |
| H0038 | Self-help/peer services, per 15 minutes | <1% | 1,189 | $24K |
| 99417 | Prolong home eval add 15m | <1% | 321 | $13K |
| 90863 | <1% | 877 | $9K | |
| 90785 | <1% | 2,103 | $7K | |
| 96127 | <1% | 1,105 | $4K | |
| T1017 | Case management, billed per 15 minutes | <1% | 44 | $2K |
| 99406 | <1% | 124 | $1K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 19 | $843.06 |
| H0032 | Mental health service plan development by non-physician | <1% | 25 | $823.37 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCOLE, RYAN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Colorado Springs Psychological Services | Colorado Springs, CO | $12.38M |
| Cole Diagnostics, INC | Boise, ID | $1.25M |
| Achieve Whole Recovery, PC | Walsenburg, CO | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.